Skip to main content
Main analysis: Prodalim 2025: The Higher-Value Shift Is Real, but Cash Proof Still Lies Ahead
ByMarch 5, 2026~10 min read

Prodalim and Solos: What 2026 Must Actually Deliver for the Platform to Become a Business

Solos now sits on real contracts, machines, and service-center buildout, but year-end 2025 still shows a platform ahead of economic scale. 2026 has to bring utilization, royalties, and visible P&L contribution, not just more dots on the map.

What Has Already Been Proved, And What Has Not

The main article argued that Prodalim cannot rely on the story of moving into higher-value categories by itself. It has to prove that the new layers can become real economics. Solos is the sharpest test of that claim, because this is not another ingredient line. It is Prodalim trying to build a global service platform around dealcoholization and aroma recovery.

The good news is that by year-end 2025 Solos is no longer just a technology narrative. The group now reports it as a separate segment, already has two German third-party service centers with company machines installed, has a joint venture in Germany, has a Swiss agreement that combines royalties with a revenue-share element, and is building owned sites in Spain and California. The balance sheet is already carrying the rollout as well: other receivables rose to $11.4 million from $6.5 million, mainly because of Solos prepayments, and property, plant and equipment rose to $59.2 million from $46.3 million, mainly because of investments in Solos service centers.

The problem is that commercialization is still much smaller than the operating buildout. In 2025 Solos generated $1.199 million of revenue, up from $1.022 million in 2024 and $632 thousand in 2023. That is real growth, but the base is still tiny, just 0.35% of group revenue. In the same year the segment posted adjusted EBITDA of negative $858 thousand and an operating loss of $1.219 million. The network is being built faster than the income statement is proving it.

That is the whole point of this follow-up. Solos has already moved past the "there is a technology" stage. It has not yet moved past the "there is a business" stage. 2026 has to prove that the centers, royalty structures, and joint-venture architecture can generate throughput, repeat revenue, and visible financial contribution.

Solos is growing, but still ahead of economic scale

The Platform Map, What Exists And What Still Needs Proof

The key thing to understand is that Solos is not one product. It is a commercialization architecture. Prodalim is building several layers at once: owned centers, third-party centers with royalty economics, and a joint venture. That is the right model for entering a new market quickly, but it also creates a recurring gap between "the footprint exists" and "the business model has been proved."

LayerWhat already existsEconomic modelWhat still counts as proof in 2026
Third-party service centers in GermanyTwo company machines are already placed in two service centersPayment by processing volumeThose sites need to show steady commercial throughput, not just presence
Solos Germany joint ventureA 50/50 joint venture, with one company machine placed in the plantServices and products at direct cost plus margin, alongside volume-based payments to ProdalimThe JV needs to generate visible revenue or expense contribution, not just corporate structure
SwitzerlandAgreement with a Swiss wine producer and its subsidiary to establish a service centerMonthly royalties by processed volume, plus a percentage of annual center revenueThe center has to open, operate commercially, and begin producing actual royalties
Owned sites in Spain and CaliforniaTwo owned sites are in advanced setup and completion stagesFully owned service centersOpening has to turn into utilization, not just fixed cost

The February and March 2026 materials make that gap very clear. On one hand, management is already presenting a global network with three distinct legs: owned centers in Spain and the US, royalty-based structures in Germany alongside a royalty and revenue-share structure in Switzerland, and a joint venture in Germany. On the other hand, as of March 5, 2026, Spain and California are still described as sites in setup and completion, while Switzerland is still framed as a center to be established and run by a third party.

The timeline language makes the same point. Valencia is presented as inaugurated in January 2026, California as planned for inauguration in the first quarter of 2026, and Hallau, Switzerland as planned for the first half of 2026. That is not necessarily a hard contradiction between documents, but it does show that the marketing narrative has already moved to the language of an active network while the economics are still in the transition from buildout to commercialization.

That matters because this is exactly where the market tends to overread the story. Opening a site is not proof of demand. It is not proof of utilization either. In Solos' case it is mainly proof that Prodalim is willing to put capex, lease commitments, and operating infrastructure in place before the numbers fully arrive.

The Commercial Model Is Smart, But It Is Not Frictionless

One of the most interesting details sits inside the contract architecture itself. Prodalim is not just building a network of sites. It is also distributing ownership, economics, and execution burden across several models.

The German joint venture is interesting precisely because it still lacks accounting proof. The agreement was signed in March 2025, each side holds 50%, and FlavoLogic is entitled to payments derived from the volume of liquids and alcohol processed through the machine. That structure makes sense. If the local partner brings operating access and Prodalim brings the technology layer, each party sits where it has an advantage. But as of March 5, 2026, no material revenue or expenses had yet arisen from Solos Germany. From a reporting perspective, the JV is still proof of direction rather than proof of commercialization.

The more important clue sits in the April 2024 development cooperation agreement with the German partner specialized in dealcoholization of fermented solutions. Under that agreement, the partner leads the design, manufacturing, supply, and installation of dealcoholization systems and service centers for the group or its customers, while Prodalim contributes its proprietary aroma-recovery module. More than that, Prodalim agreed to prefer that partner as the preferred supplier for the dealcoholization portion of relevant projects, and also agreed not to build or distribute industrial-scale dealcoholization systems based on the partner's technology without consent.

That does not mean Solos has a weak moat. Quite the opposite, the aroma-recovery technology and related patents remain with the group, and the partner committed not to develop or market competing technologies in that area. But it does reveal an important structure between the lines: Solos controls the aroma layer and much of the commercialization architecture, not necessarily the entire industrial equipment chain end to end. So even if demand arrives, rollout speed and execution still depend in part on an external partner's ability to supply systems, hit timelines, and remain competitively priced.

The Swiss agreement sharpens the opposite side of the story. Here the model already looks almost like an industrial platform model: Prodalim installs an aroma-recovery system, leases it out, grants a limited non-exclusive license, and earns both monthly volume-based royalties and an additional payment tied to a percentage of the center's annual revenue. This is exactly the kind of model that can become far more attractive than a plain service model if throughput arrives. But it still requires one very simple thing, volume. Without real customer traffic and repeated use of the center, that agreement remains strategically right but economically empty.

Where The Economic Case Still Falls Short

This is the easiest point to miss. If you look only at the footprint map, you might think Solos has already crossed the proof threshold. If you look at the segment itself, it clearly has not.

Yes, revenue was up 17.3% in 2025. Yes, gross profit rose to $947 thousand from $793 thousand. But adjusted EBITDA remained negative at $858 thousand versus negative $852 thousand in 2024, and the operating loss widened to $1.219 million from $1.055 million. That is not a collapse, but it is also not a business model that already shows the network can carry itself.

What really matters is that the 2025 numbers show two things that each look good on their own, but have not yet met. On one hand, revenue has almost doubled in two years, from $632 thousand in 2023 to $1.199 million in 2025. On the other hand, the cost base is already being built as if the system is close to becoming a real service platform. If 2026 does not bring a sharper jump in sales and utilization, that gap only becomes more obvious.

The balance sheet is already telling the same story. Prepayments tied mainly to Solos are rising, fixed assets are climbing because of investment in service centers, and cash used in investing activities has jumped sharply, even though the French acquisition is also part of that line. Prodalim is already spending as if Solos is on its way to becoming a real operating leg. Revenue has not yet validated that cost base.

That is why the right question for 2026 is not "will another site open." The right question is whether those openings change the numbers. Without that, Solos remains an interesting strategic option, not a proved economic engine.

What 2026 Must Actually Deliver

The first proof point: move from inauguration to utilization. Valencia, California, and Switzerland have to show real work, not just site openings and geographic markers.

The second proof point: the first visible revenue from the new models. If Swiss royalties, German volume-based payments, or meaningful JV contribution start to appear, that will be the most important change in how Solos is read.

The third proof point: real acceleration in segment revenue. After 17.3% growth in 2025, 2026 needs a materially faster pace. A global network under construction does not justify another small move in the hundreds of thousands of dollars.

The fourth proof point: a clearer direction in profitability. Immediate profit is not the right demand, but the network does have to start closing the gap between revenue and cost. If revenue rises while the loss barely changes, that would be a strong signal that the platform is still far from economic scale.

This is also where the market reading can shift over the short and medium term. If 2026 mostly brings more buildout, more sites, and more strategy language without clear recurring revenue and utilization, Solos will read like a cost center built ahead of demand. If, instead, royalties, throughput, and visibly larger segment contribution begin to show up, the broader Prodalim story around moving into higher-value layers starts to carry very different weight.

Bottom Line

Solos now looks like a real platform, not a pilot. There is a network under construction, there are contracts with royalty and revenue-share mechanics, there are partners, and there is already revenue. But year-end 2025 also makes clear that it is still not a business at scale. The segment is too small, the German JV still has not delivered material contribution, and the move from buildout to commercialization is not yet visible in the numbers.

That is why 2026 is a proof year, not a story year. What matters is not how many sites appear on the map, but how many of them actually work, at what throughput, and at what pace they begin to close the gap between global footprint and operating economics. That is the difference between an interesting technology and a business.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction